View in EDS

Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics.

Saved in:
Bibliographic Details
Title: Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics.
Authors: Gérard A; HiFiBiO Therapeutics SAS, Paris, France., Woolfe A; HiFiBiO Therapeutics SAS, Paris, France., Mottet G; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France., Reichen M; HiFiBiO Therapeutics SAS, Paris, France., Castrillon C; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., Menrath V; HiFiBiO Therapeutics SAS, Paris, France., Ellouze S; HiFiBiO Therapeutics SAS, Paris, France., Poitou A; HiFiBiO Therapeutics SAS, Paris, France., Doineau R; HiFiBiO Therapeutics SAS, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Institute for Integrative Nanosciences, Leibniz IFW Dresden e.V., Dresden, Germany., Briseno-Roa L; HiFiBiO Therapeutics SAS, Paris, France.; Medetia Pharma, Institut Imagine, Paris, France., Canales-Herrerias P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., Mary P; HiFiBiO Therapeutics Inc., Cambridge, MA, USA., Rose G; HiFiBiO Therapeutics Inc., Cambridge, MA, USA., Ortega C; HiFiBiO Therapeutics Inc., Cambridge, MA, USA., Delincé M; HiFiBiO Therapeutics Inc., Cambridge, MA, USA., Essono S; HiFiBiO Therapeutics Inc., Cambridge, MA, USA., Jia B; Pfizer, Cambridge, MA, USA.; Abbvie Bioresearch Center, Worcester, MA, USA., Iannascoli B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France., Richard-Le Goff O; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France., Kumar R; HiFiBiO Therapeutics Inc., Cambridge, MA, USA., Stewart SN; HiFiBiO Therapeutics Inc., Cambridge, MA, USA., Pousse Y; HiFiBiO Therapeutics SAS, Paris, France., Shen B; HiFiBiO Therapeutics SAS, Paris, France., Grosselin K; HiFiBiO Therapeutics SAS, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., Saudemont B; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., Sautel-Caillé A; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., Godina A; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., McNamara S; HiFiBiO Therapeutics SAS, Paris, France., Eyer K; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Laboratory for Functional Immune Repertoire Analysis, Institute of Pharmaceutical Sciences, D-CHAB, ETH Zürich, Zurich, Switzerland., Millot GA; Institut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France., Baudry J; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., England P; Plateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France.; Centre d'Innovation et de Technologie, Plateforme de Biophysique des Macromolecules et de leurs Interactions, Institut Pasteur, Paris, France., Nizak C; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France., Jensen A; HiFiBiO Therapeutics SAS, Paris, France.; Lundbeck A/S, Valby, Denmark., Griffiths AD; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France. andrew.griffiths@espci.fr., Bruhns P; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France. pierre.bruhns@pasteur.fr., Brenan C; HiFiBiO Therapeutics SAS, Paris, France. c.brenan@1cell-bio.com.; HiFiBiO Therapeutics Inc., Cambridge, MA, USA. c.brenan@1cell-bio.com.; 1CellBiO Inc., Watertown, MA, USA. c.brenan@1cell-bio.com.
Source: Nature biotechnology [Nat Biotechnol] 2020 Jun; Vol. 38 (6), pp. 756.
Publication Type: Journal Article; Published Erratum
Journal Info: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32444853
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gérard+A%22">Gérard A</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Woolfe+A%22">Woolfe A</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mottet+G%22">Mottet G</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Reichen+M%22">Reichen M</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Castrillon+C%22">Castrillon C</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.<br /><searchLink fieldCode="AU" term="%22Menrath+V%22">Menrath V</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ellouze+S%22">Ellouze S</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Poitou+A%22">Poitou A</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Doineau+R%22">Doineau R</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Institute for Integrative Nanosciences, Leibniz IFW Dresden e.V., Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Briseno-Roa+L%22">Briseno-Roa L</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.; Medetia Pharma, Institut Imagine, Paris, France.<br /><searchLink fieldCode="AU" term="%22Canales-Herrerias+P%22">Canales-Herrerias P</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; École Doctorale Frontières du Vivant (FdV), Centre de Recherches Interdisciplinaires, Paris, France.; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mary+P%22">Mary P</searchLink>; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rose+G%22">Rose G</searchLink>; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ortega+C%22">Ortega C</searchLink>; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Delincé+M%22">Delincé M</searchLink>; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Essono+S%22">Essono S</searchLink>; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jia+B%22">Jia B</searchLink>; Pfizer, Cambridge, MA, USA.; Abbvie Bioresearch Center, Worcester, MA, USA.<br /><searchLink fieldCode="AU" term="%22Iannascoli+B%22">Iannascoli B</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Richard-Le+Goff+O%22">Richard-Le Goff O</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.<br /><searchLink fieldCode="AU" term="%22Kumar+R%22">Kumar R</searchLink>; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+SN%22">Stewart SN</searchLink>; HiFiBiO Therapeutics Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pousse+Y%22">Pousse Y</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Shen+B%22">Shen B</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Grosselin+K%22">Grosselin K</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.<br /><searchLink fieldCode="AU" term="%22Saudemont+B%22">Saudemont B</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France.; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sautel-Caillé+A%22">Sautel-Caillé A</searchLink>; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.<br /><searchLink fieldCode="AU" term="%22Godina+A%22">Godina A</searchLink>; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.<br /><searchLink fieldCode="AU" term="%22McNamara+S%22">McNamara S</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Eyer+K%22">Eyer K</searchLink>; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.; Laboratory for Functional Immune Repertoire Analysis, Institute of Pharmaceutical Sciences, D-CHAB, ETH Zürich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Millot+GA%22">Millot GA</searchLink>; Institut Pasteur, Hub Bioinformatique et Biostatistique, C3BI, USR 3756 IP CNRS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Baudry+J%22">Baudry J</searchLink>; Laboratoire Colloïdes et Matériaux Divisés (LCMD), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.<br /><searchLink fieldCode="AU" term="%22England+P%22">England P</searchLink>; Plateforme de Biophysique Moléculaire, Institut Pasteur, CNRS UMR3528, Paris, France.; Centre d'Innovation et de Technologie, Plateforme de Biophysique des Macromolecules et de leurs Interactions, Institut Pasteur, Paris, France.<br /><searchLink fieldCode="AU" term="%22Nizak+C%22">Nizak C</searchLink>; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France.<br /><searchLink fieldCode="AU" term="%22Jensen+A%22">Jensen A</searchLink>; HiFiBiO Therapeutics SAS, Paris, France.; Lundbeck A/S, Valby, Denmark.<br /><searchLink fieldCode="AU" term="%22Griffiths+AD%22">Griffiths AD</searchLink>; Laboratoire de Biochimie (LBC), ESPCI Paris, PSL Research University, CNRS UMR8231 Chimie Biologie Innovation, Paris, France. andrew.griffiths@espci.fr.<br /><searchLink fieldCode="AU" term="%22Bruhns+P%22">Bruhns P</searchLink>; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, Paris, France. pierre.bruhns@pasteur.fr.<br /><searchLink fieldCode="AU" term="%22Brenan+C%22">Brenan C</searchLink>; HiFiBiO Therapeutics SAS, Paris, France. c.brenan@1cell-bio.com.; HiFiBiO Therapeutics Inc., Cambridge, MA, USA. c.brenan@1cell-bio.com.; 1CellBiO Inc., Watertown, MA, USA. c.brenan@1cell-bio.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229604648%22">Nature biotechnology</searchLink> [Nat Biotechnol] 2020 Jun; Vol. 38 (6), pp. 756.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+America+Publishing%22">Nature America Publishing </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9604648 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-1696 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210870156%22">10870156 </searchLink><i>NLM ISO Abbreviation: </i>Nat Biotechnol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32444853
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41587-020-0563-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 756
    Titles:
      – TitleFull: Author Correction: High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gérard A
      – PersonEntity:
          Name:
            NameFull: Woolfe A
      – PersonEntity:
          Name:
            NameFull: Mottet G
      – PersonEntity:
          Name:
            NameFull: Reichen M
      – PersonEntity:
          Name:
            NameFull: Castrillon C
      – PersonEntity:
          Name:
            NameFull: Menrath V
      – PersonEntity:
          Name:
            NameFull: Ellouze S
      – PersonEntity:
          Name:
            NameFull: Poitou A
      – PersonEntity:
          Name:
            NameFull: Doineau R
      – PersonEntity:
          Name:
            NameFull: Briseno-Roa L
      – PersonEntity:
          Name:
            NameFull: Canales-Herrerias P
      – PersonEntity:
          Name:
            NameFull: Mary P
      – PersonEntity:
          Name:
            NameFull: Rose G
      – PersonEntity:
          Name:
            NameFull: Ortega C
      – PersonEntity:
          Name:
            NameFull: Delincé M
      – PersonEntity:
          Name:
            NameFull: Essono S
      – PersonEntity:
          Name:
            NameFull: Jia B
      – PersonEntity:
          Name:
            NameFull: Iannascoli B
      – PersonEntity:
          Name:
            NameFull: Richard-Le Goff O
      – PersonEntity:
          Name:
            NameFull: Kumar R
      – PersonEntity:
          Name:
            NameFull: Stewart SN
      – PersonEntity:
          Name:
            NameFull: Pousse Y
      – PersonEntity:
          Name:
            NameFull: Shen B
      – PersonEntity:
          Name:
            NameFull: Grosselin K
      – PersonEntity:
          Name:
            NameFull: Saudemont B
      – PersonEntity:
          Name:
            NameFull: Sautel-Caillé A
      – PersonEntity:
          Name:
            NameFull: Godina A
      – PersonEntity:
          Name:
            NameFull: McNamara S
      – PersonEntity:
          Name:
            NameFull: Eyer K
      – PersonEntity:
          Name:
            NameFull: Millot GA
      – PersonEntity:
          Name:
            NameFull: Baudry J
      – PersonEntity:
          Name:
            NameFull: England P
      – PersonEntity:
          Name:
            NameFull: Nizak C
      – PersonEntity:
          Name:
            NameFull: Jensen A
      – PersonEntity:
          Name:
            NameFull: Griffiths AD
      – PersonEntity:
          Name:
            NameFull: Bruhns P
      – PersonEntity:
          Name:
            NameFull: Brenan C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2020 Jun
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1546-1696
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Nature biotechnology
              Type: main
ResultId 1